In the highly regulated field of pharmaceutical manufacturing, the quality of raw materials and intermediates is paramount. NINGBO INNO PHARMCHEM CO.,LTD. understands this critical requirement and is committed to supplying N4-Acetylcytosine that meets the highest industry standards. As a vital intermediate, N4-Acetylcytosine (CAS: 14631-20-0) is integral to the synthesis of powerful anti-tumor and anti-viral medications.

The intrinsic value of N4-Acetylcytosine lies in its precise chemical composition and exceptional purity. With an assay of u226599.0% determined by HPLC, this compound provides the reliability that pharmaceutical developers need to ensure the efficacy and safety of their final drug products. The low loss on drying (u22641.0%) further indicates its stability and quality, making it an ideal choice for complex synthesis pathways.

For any company looking to buy N4-Acetylcytosine, the decision of supplier significantly impacts the overall success of their production. Choosing a reputable provider ensures that the synthesis of N4-Acetylcytosine has been conducted under strict quality control, guaranteeing batch-to-batch consistency. This is particularly important when these intermediates are used for the production of anti-tumor agents, where even minor impurities can affect therapeutic outcomes.

The strategic importance of N4-Acetylcytosine in pharmaceutical synthesis cannot be overstated. Its role in the creation of anti-viral drugs is equally significant, contributing to the global effort to combat infectious diseases. The consistent demand for this intermediate highlights its broad applicability and essential nature in modern medicine.

At NINGBO INNO PHARMCHEM CO.,LTD., we pride ourselves on being a dependable source for high-quality N4-Acetylcytosine. We understand the critical role this compound plays in the pharmaceutical industry and are dedicated to supporting our clients’ R&D and manufacturing goals. By ensuring the purity and availability of N4-Acetylcytosine, we empower our partners to bring life-saving anti-viral and anti-tumor therapies to market.